SCHEMBL4334148

SCHEMBL4334148

CC(C)O[C@@H](Cc1cccc(CNC(=O)OCc2ccc(C(C)C)cc2)c1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
KMT2A Q03164 1/20 0.44
PPARG P37231 3/20 0.43
PPARA Q07869 3/20 0.43
PPARD Q03181 1/20 0.43
PLAU P00749 1/20 0.42
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSS P25774 1/20 0.40
TPSAB1 Q15661 2/20 0.39
PLG P00747 1/20 0.39
PRSS1 P07477 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334159 1.00 MEN1 (0.44) MEN1LMNAKMT2APPARGPPARA
SCHEMBL4342511 0.92 PPARA (0.45) PPARGPPARAPPARDPLAU
SCHEMBL4329078 0.92 PPARA (0.45) PPARGPPARAPPARDPLAU
SCHEMBL4329382 0.91 MAPT (0.47) PPARGPPARAPLAUL3MBTL1CTSL
SCHEMBL4329379 0.91 MAPT (0.47) PPARGPPARAPLAUL3MBTL1CTSL
SCHEMBL4339680 0.91 GAA (0.45) PPARGPPARAPPARDPLAUL3MBTL1
SCHEMBL4339677 0.91 GAA (0.45) PPARGPPARAPPARDPLAUL3MBTL1
SCHEMBL4339692 0.90 PPARG (0.45) LMNAPPARGPPARAPPARDPLAU
SCHEMBL4334662 0.89 NPC1 (0.50) PPARGPPARAPPARDPLAU
SCHEMBL4336082 0.89 ATM (0.47) PPARGPPARAALDH1A1CTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MEN1 4091/4885LMNA 3790/4885KMT2A 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.